Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats

References

• Bekoe NA, Li Q, Ashraf F, O’Brien TP. 1999. Effects of ciprofloxacin, ofloxacin and gentamicin on corneal cells and wound healing. Invest Ophthalmol Vis Sci 40:S548–S551
   Google Scholar
• Blondeau JM. 2004. Fluoroquinolones: mechanism of action, classification and development of resistance. Surv Ophthalmol 49:S73–S78
   PubMed Web of Science ®Google Scholar
• Chotikavanich S, DePaiva CS, Li de Q, Chen JJ, Bian F, Farley WJ, Pflugfelder SC. 2009. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 50:3203–3209.
   PubMed Web of Science ®Google Scholar
• Collin HB, Grabsch BE. 1982. The effect of ophthalmic preservatives on the healing rate of the rabbit corneal epithelium after keratectomy. Am J Optom Physiol Opt 59:215–222.
   PubMedGoogle Scholar
• Corps AN, Harrall RL, Curry VA, Hazleman BL, Riley GP. 2005. Contrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells. Rheumatology 44:1514–1517.
   PubMedGoogle Scholar
• Fini ME, Girard MT, Matsubara M, Bartlett JD. 1995. Unique regulation of the matrix metalloproteinase, gelatinase B. Invest Ophthalmol Vis Sci 36:622–633.
   PubMed Web of Science ®Google Scholar
• Fini ME, Parks WC, Rinehart WB, Girard MT, Matsubara M, Cook JR, West-Mays JA, Sadow PM, Burgeson RE, Jeffrey JJ, Raizman MB, Krueger RR, Zieske JD. 1996. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 49:1287–1302.
   Google Scholar
• Gangopadhyay N, Daniell M, Weih L, Taylor HR. 2000. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol 84:378–384.
   PubMed Web of Science ®Google Scholar
• Garrana RM, Zieske JD, Assouline M, Gipson IK. 1999. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest Ophthalmol Vis Sci 40:1266–1270.
   PubMed Web of Science ®Google Scholar
• Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. 1997. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5. Science 277:225–228.
   PubMed Web of Science ®Google Scholar
• Gordon GM, Ledee DR, Feuer WJ, Fini ME. 2009. Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells. J Cell Physiol 221:402–411.
   PubMedGoogle Scholar
• Haruta Y, Ohashi Y, Matsuda S. 1997. Corneal epithelial deficiency induced by the use of beta-blocker eye drops. Eur J Ophthalmol 7:334–339.
   PubMedGoogle Scholar
• Hayashi K, Hooper LC, Detrick B, Hooks JJ. 2009. SV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9. Arch Virol 154:219–226.
   PubMed Web of Science ®Google Scholar
• Higgins K. 1991. Potential toxicity of ciprofloxacin. Ophthalmology 98:120–121.
   PubMedGoogle Scholar
• Kleiner DE, Steller-Stevenson WG. 1994. Quantitative zymography detection of picogram quantities of gelatinases. Ann Biochem 218:325–329
   Google Scholar
• Lee S, Zheng M, Kim B, Rouse BT. 2002. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110:1105–1111.
   PubMed Web of Science ®Google Scholar
• Li DQ, Pflugfelder SC. 2005. Matrix metalloproteinases in corneal inflammation. Ocul Surf 3:198–202.
   Web of Science ®Google Scholar
• Mallari PLT, McCarty DJ, Daniell M, Taylor H. 2001. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 131:131–133.
   PubMed Web of Science ®Google Scholar
• Matsubara M, Zieske JD, Fini ME. 1991. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 32:3221–3237.
   PubMed Web of Science ®Google Scholar
• Miyajima S, Akaike T, Matsumoto K, Okamoto T, Yoshitake J, Hayashida K, Negi A, Maeda H. 2001. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathog 31:271–281.
   PubMedGoogle Scholar
• Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA, Lee Y, McCarthy BE, Wollenberg KR, Jester JV, Wang M, Welgus HG, Shipley JM, Senior RM, Fini ME. 2002. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 277:2065–2072.
   PubMed Web of Science ®Google Scholar
• O’Brien TP, Li QJ, Sauerburger F, Reviglio VE. 2001. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology 108:656–659.
   PubMed Web of Science ®Google Scholar
• Patel GM, Chuang AZ, Kiang E, Ramesh N, Mitra S, Yee RW. 2000. Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy. J Cataract Refract Surg 26:690–694.
   PubMed Web of Science ®Google Scholar
• Reviglio VE, Hakim MA, Song JK, O’Brien TP. 2003. Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. BMC Ophthalmol 3:1–8.
   PubMedGoogle Scholar
• Seitz B, Hayashi S, Wee WR, LaBree L, McDonnell PJ. 1996. In vitro effects of aminoglycosides and fluoroquinolones on keratocytes. Invest Ophthal Vis Sci 37:656–665.
   PubMed Web of Science ®Google Scholar
• Sivak JM, Fini ME. 2002. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 21:1–14.
   PubMed Web of Science ®Google Scholar
• Smith A, Pennefather PM, Kaye SB, Hart CA. 2001. Fluoroquinolones: place in ocular therapy. Drugs 61:747–761.
   PubMed Web of Science ®Google Scholar
• Smith VA, Easty DL. 2000. Matrix metalloproteinase-2: involvement in keratoconus. Eur J Ophthalmol 10:215–226.
   PubMedGoogle Scholar
• Thompson AM. 2007. Ocular toxicity of fluoroquinolones. Clin Exp Ophthalmol 35:566–577.
   PubMed Web of Science ®Google Scholar